V. L. Feigin, A. A. Abajobir, and K. H. Abate, Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study, Lancet Neurol, vol.16, issue.11, pp.877-97, 2015.

C. C. John, H. Carabin, S. M. Montano, P. Bangirana, J. R. Zunt et al., Global research priorities for infections that affect the nervous system, Nature, vol.527, issue.7578, pp.178-86, 2015.

M. L. Wilson, K. A. Fleming, M. A. Kuti, L. M. Looi, N. Lago et al., Access to pathology and laboratory medicine services: a crucial gap, The Lancet, vol.391, pp.1927-1965, 2018.

A. Nath, Grand challenges in neuroinfectious diseases, Front Neurol, vol.8, p.480, 2017.

F. Zi-yvonne-chan, L. Wijaya, and K. Tan, Epidemiology, outcomes and prognosis of central nervous system infections in Singapore, Preliminary results from The Singapore Neurologic Infections Programme, 2017.

R. Backman, R. Foy, and P. J. Diggle, A pragmatic cluster randomised controlled trial of a tailored intervention to improve the initial management of suspected encephalitis, PLoS ONE, vol.13, issue.12, p.202257, 2018.

F. Mcgill, M. J. Griffiths, and L. J. Bonnett, Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study, Lancet Infect Dis, vol.18, issue.9, pp.992-1003, 2018.

J. Granerod, R. Cunningham, and M. Zuckerman, Causality in acute encephalitis: defining aetiologies, Epidemiol Infect, vol.138, issue.6, pp.783-800, 2010.

J. R. Brown, T. Bharucha, and J. Breuer, Encephalitis diagnosis using metagenomics: application of next generation sequencing for undiagnosed cases, J Infect, 2018.

J. Granerod, H. E. Ambrose, and N. W. Davies, Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study, Lancet Infect Dis, vol.10, issue.12, pp.835-879, 2010.

R. D. Schubert and M. R. Wilson, A tale of two approaches: how metagenomics and proteomics are shaping the future of encephalitis diagnostics, Curr Opin Neurol, vol.28, issue.3, pp.283-290, 2015.

M. R. Wilson, H. A. Sample, and K. C. Zorn, Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis, N Engl J Med, vol.380, issue.24, pp.2327-2367, 2019.

B. Anlar, Chapter 123 -Subacute sclerosing panencephalitis and chronic viral encephalitis, Handbook of Clinical Neurology, pp.1183-1192, 2013.

J. R. Brown, S. Morfopoulou, and J. Hubb, Astrovirus VA1/HMO-C: an increasingly recognized neurotropic pathogen in immunocompromised patients, Clinic Infect Dis Offic Publ Infect Dis Soc Am, vol.60, issue.6, pp.881-889, 2015.

S. Cordey, D. Vu, and M. Schibler, Astrovirus MLB2, a new gastroenteric virus associated with meningitis and disseminated infection, Emerg Infect Dis, vol.22, issue.5, pp.846-53, 2016.

P. L. Quan, T. A. Wagner, and T. Briese, Astrovirus encephalitis in boy with X-linked agammaglobulinemia, Emerg Infect Dis, vol.16, issue.6, pp.918-943, 2010.

L. A. Benjamin, P. Lewthwaite, and R. Vasanthapuram, Human parvovirus 4 as potential cause of encephalitis in children, India. Emerg Infect Dis, vol.17, issue.8, pp.1484-1491, 2011.

G. Palacios, J. Druce, and L. Du, A new arenavirus in a cluster of fatal transplant-associated diseases, N Engl J Med, vol.358, issue.10, pp.991-999, 2008.

C. D. French, R. E. Willoughby, and A. Pan, NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system, PLoS Negl Trop Dis, vol.12, issue.12, 2018.

H. D. Gliddon, J. A. Herberg, M. Levin, and M. Kaforou, Genome-wide host RNA signatures of infectious diseases: discovery and clinical translation, Immunology, vol.153, issue.2, pp.171-179, 2018.

J. D. Keene, The global dynamics of RNA stability orchestrates responses to cellular activation, BMC Biol, vol.8, issue.1, p.95, 2010.

I. Gertsman and B. A. Barshop, Promises and pitfalls of untargeted metabolomics, J Inherit Metab Dis, vol.41, issue.3, pp.355-66, 2018.

F. M. Araujo, R. S. Brilhante, and L. P. Cavalcanti, Detection of the dengue non-structural 1 antigen in cerebral spinal fluid samples using a commercially available enzyme-linked immunosorbent assay, J Virol Methods, vol.177, issue.1, pp.128-159, 2011.

D. A. Muller, A. C. Depelsenaire, and P. R. Young, Clinical and laboratory diagnosis of dengue virus infection, J Infect Dis, vol.215, issue.suppl_2, pp.89-95, 2017.

W. M. Scheld, R. J. Whitley, and C. M. Marra, Infections of the Central Nervous System, 2014.

A. Venkatesan, B. D. Michael, J. C. Probasco, R. G. Geocadin, and T. Solomon, Acute encephalitis in immunocompetent adults, The Lancet, vol.393, pp.702-718, 2019.

E. J. Thompson, Proteins of the Cerebrospinal Fluid: Analysis & Interpretation in the Diagnosis and Treatment of Neurological Disease, 2005.

A. S. Ptolemy and N. Rifai, What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema, Scand J Clinic Lab Invest, vol.242, pp.6-14, 2010.

V. Sandalakis, I. Goniotakis, I. Vranakis, D. Chochlakis, and A. Psaroulaki, Use of MALDI-TOF mass spectrometry in the battle against bacterial infectious diseases: recent achievements and future perspectives, Expert Rev Proteomics, vol.14, issue.3, pp.253-67, 2017.

E. Baker, T. Liu, and V. Petyuk, Mass spectrometry for translational proteomics: Progress and clinical implications, 2012.

H. J. Issaq and T. D. Veenstra, Proteomic and Metabolomic Approaches to Biomarker Discovery, 2013.

C. E. Teunissen, A. Malekzadeh, C. Leurs, C. Bridel, and J. Killestein, Body fluid biomarkers for multiple sclerosis-the long road to clinical application, Nat Rev Neurol, vol.11, issue.10, pp.585-96, 2015.

A. L. Oberg and O. Vitek, Statistical design of quantitative mass spectrometry-based proteomic experiments, J Proteome Res, vol.8, issue.5, pp.2144-56, 2009.

H. Mischak, G. Allmaier, and R. Apweiler, Recommendations for biomarker identification and qualification in clinical proteomics, Sci Transl Med, vol.2, issue.46, pp.46-48, 2010.

S. Gnanapavan, H. Hegen, and M. Khalil, Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders, Neurology, vol.83, issue.13, pp.1210-1226, 2014.

J. O. Fleming and C. M. Carlsson, Biomarkers for neurology: guides and lines, Neurology, vol.83, issue.13, pp.1130-1131, 2014.

C. Teunissen, T. Menge, and A. Altintas, Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis, Mult Scler, vol.19, issue.13, pp.1802-1811, 2013.

C. E. Teunissen, M. Otto, and S. Engelborghs, White paper by the society for CSF analysis and clinical neurochemistry: overcoming barriers in biomarker development and clinical translation, Alzheimers Res Ther, vol.10, issue.1, p.30, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01842202

C. E. Teunissen, A. Petzold, and J. L. Bennett, A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking, Neurology, vol.73, issue.22, pp.1914-1936, 2009.

T. E. Angel, J. M. Jacobs, and R. P. Smith, Cerebrospinal fluid proteome of patients with acute Lyme disease, J Proteome Res, vol.11, issue.10, pp.4814-4836, 2012.

T. Asano, S. Koizumi, and A. Takagi, Identification of a novel biomarker candidate, a 4.8-kDa peptide fragment from a neurosecretory protein VGF precursor, by proteomic analysis of cerebrospinal fluid from children with acute encephalopathy using SELDI-TOF-MS, BMC Neurol, vol.11, issue.101, 2011.

A. P. Cordeiro, R. Pereira, and A. Chapeaurouge, Comparative proteomics of cerebrospinal fluid reveals a predictive model for differential diagnosis of pneumococcal, meningococcal, and enteroviral meningitis, and novel putative therapeutic targets, BMC Genom, vol.16, p.9, 2015.

C. Fraisier, A. Papa, and S. Granjeaud, Cerebrospinal fluid biomarker candidates associated with human WNV neuroinvasive disease, PLoS ONE, vol.9, issue.4, p.93637, 2014.

G. Gomez-baena, R. J. Bennett, and C. Martinez-rodriguez, Quantitative proteomics of cerebrospinal fluid in paediatric pneumococcal meningitis, Sci Rep, vol.7, p.11, 2017.

J. Mu, Y. Yang, and J. Chen, Elevated host lipid metabolism revealed by iTRAQ-based quantitative proteomic analysis of cerebrospinal fluid of tuberculous meningitis patients, Biochem Biophys Res Commun, vol.466, issue.4, pp.689-695, 2015.

J. M. Njunge, Cerebrospinal fluid markers to distinguish bacterial meningitis from cerebral malaria in children, Am J Tropic Med Hygiene, vol.97, issue.5, pp.209-219, 2017.

Q. Ou, X. Liu, and X. Cheng, An iTRAQ approach to quantitative proteome analysis of cerebrospinal fluid from patients with tuberculous meningitis, Biosci Trends, vol.7, issue.4, pp.186-92, 2013.

S. E. Schutzer, T. E. Angel, and T. Liu, Distinct cerebrospinal fluid proteomes differentiate post-treatment Lyme disease from chronic fatigue syndrome, PLoS ONE, vol.6, issue.2, p.17287, 2011.

N. Sengupta, S. Mukherjee, P. Tripathi, R. Kumar, A. Suryavanshi et al., Cerebrospinal fluid biomarkers of Japanese encephalitis, vol.4, p.334, 2015.

N. Tiberti, V. Lejon, M. Ngoyi, and D. , Increased acute immune response during the meningo-encephalitic stage of Trypanosoma brucei rhodesiense sleeping sickness compared to Trypanosoma brucei gambiense, Transl Proteom, vol.6, pp.1-9, 2015.

Y. Yang, J. Mu, and G. Chen, iTRAQ-based quantitative proteomic analysis of cerebrospinal fluid reveals NELL2 as a potential diagnostic biomarker of tuberculous meningitis, Int J Mol Med, vol.35, issue.5, pp.1323-1355, 2015.

N. Tiberti and J. C. Sanchez, Comparative analysis of cerebrospinal fluid from the meningo-encephalitic stage of T. b. gambiense and rhodesiense sleeping sickness patients using TMT quantitative proteomics, Data Brief, vol.4, pp.400-405, 2015.

J. Bonnet, C. Garcia, and T. Leger, Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects, J Proteomics, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01936184

T. Consortium, Expansion of the gene ontology knowledgebase and resources, Nucleic Acids Res, vol.45, issue.D1, pp.331-334, 2017.

D. Szklarczyk, J. H. Morris, and H. Cook, The string database in 2017: quality-controlled protein-protein association networks, made broadly accessible, Nucleic Acids Res, vol.45, issue.D1, pp.362-365, 2017.

L. Martens, H. Hermjakob, and P. Jones, PRIDE: the proteomics identifications database, Proteomics, vol.5, issue.13, pp.3537-3582, 2005.

R. J. , The human genome project, The Lancet, vol.334, issue.8678, pp.1535-1541, 1989.

J. Ioannidis and P. Bossuyt, Waste, leaks, and failures in the biomarker pipeline, Clin Chem, vol.63, issue.5, pp.963-72, 2017.

A. Breiner, D. Moher, and J. Brooks, Adult CSF total protein upper reference limits should be age-partitioned and significantly higher than 0.45 g/L: a systematic review, J Neurol, 2019.

G. A. Van-raemdonck, K. K. Osbak, X. Van-ostade, and C. R. Kenyon, Needle lost in the haystack: multiple reaction monitoring fails to detect Treponema pallidum candidate protein biomarkers in plasma and urine samples from individuals with syphilis, vol.7, p.336, 2018.

C. Macron, L. Lane, N. Galindo, A. Dayon, and L. , Deep dive on the proteome of human cerebrospinal fluid: a valuable data resource for biomarker discovery and missing protein identification, J Proteome Res, vol.17, issue.12, pp.4113-4139, 2018.

M. Kuhn, K. W. Suhs, and M. K. Akmatov, Mass-spectrometric profiling of cerebrospinal fluid reveals metabolite biomarkers for CNS involvement in varicella zoster virus reactivation, J Neuroinflamm, vol.15, issue.1, p.20, 2018.

N. Rifai, I. D. Watson, and W. G. Miller, Commercial immunoassays in biomarkers studies: researchers beware, Clin Chem, vol.58, issue.10, pp.1387-1395, 2012.

M. A. Valentin, S. Ma, A. Zhao, F. Legay, and A. Avrameas, Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support preclinical and clinical studies, J Pharm Biomed Anal, vol.55, issue.5, pp.869-77, 2011.